Soft Tissue Repair Market size to exceed $21.4bn by 2030

Soft Tissue Repair Market size is set to surpass USD 21.4 billion by 2030, according to a new research report by Global Market Insights Inc.
 

Continuous development and breakthroughs in soft tissue repair products by various players across the globe have uplifted the market opportunities in the region. This has not only led to the emergence of an innovative tissue repair product portfolio but also increased the demand for such devices as it helps in improved and precise replacement of the injured or damaged tissues with healthy tissues.
 

From conventional soft tissue repair devices, the medical device companies have shifted their emphasis to smaller, customized, and precise offerings comprising suture anchors. These devices cater to patients in better management of soft tissue injuries related to muscles, ligaments, tendons, and skin among others. Some of the recent advancements in soft tissue mesh include the use of absorbable synthetic film to minimize unwanted tissue attachment, novel mesh design to simplify intra-operative handling for surgeons through improved visualization, etc.
 

Increasing incidence of sports injuries will boost the soft tissue repair market forecasts

Severe soft tissue sports injuries may require surgical procedures to repair the damage. Many of these surgeries can be performed arthroscopically, meaning a minimally invasive procedure in that small incisions are made to repair the damage. Several hospitals are also focusing to deliver such repair procedures with an overnight hospital stay and optimum outcomes. Hence, with the growing participation in sports and rising incidence of sports injuries, the demand for injured or damaged soft tissue management is expected to upsurge across the globe.
 

Several advantages offered by tissue fixation devices will fuel the preference for these devices

Soft tissue repair market from tissue fixation devices segment crossed USD 3.5 billion in 2021. This is attributed to rising demand and increasing awareness related to extensive advantages delivered by the tissue fixation devices comprising suture anchors in orthopedic repair, skin repair, etc. The advent of novel soft tissue fixation devices comprising suture kits provides technology that allows the tension and the ability to attach tendon or tendon graft directly to the bone inside a pre-drilled socket. The Knotless SutureTak anchor developed by Arthrex streamlines arthroscopic glenohumeral joint instability reparation by integrating an insertion procedure and reproducible suture anchor design with knotless soft tissue fixation.
 

Browse key industry insights spread across 218 pages with 333 market data tables & 16 figures & charts from the report, “Soft Tissue Repair Market Analysis By Product (Tissue Patch/Matrix {Biological Mesh [Allograft, Xenograft], Synthetic Mesh}, Tissue Fixation Devices {Suture Anchor, Sutures, Interference Screws}), Application (Hernia Repair, Orthopedic, Skin Repair, Dural Repair), End-use (Hospitals, Ambulatory Surgical Centers, Clinics), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 – 2030” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/soft-tissue-repair-market
 

Innovations and the advent of novel soft tissue products in hernia repair will spur the soft tissue repair market expansion

Hernia repair segment accounted for 34% revenue share in 2021 and is projected to witness a similar trend during the analysis period. This is attributable to the rising prevalence of hernia, increasing demand for hernia mesh in hernia tissue repair surgeries, etc. The prevalence rate of inguinal hernias upsurges in children aged 5 and in people aged 70 & above. Attributable to this high prevalence rate, over 800,000 inguinal repairs are performed every year in the U.S. The preference for soft tissue repair products is significantly surging owing to its benefits in healing the damaged tissue around hernias.
 

Growing adoption of soft tissue repair products in the ambulatory surgical centers will drive the soft tissue repair market outlook

Ambulatory surgical centers segment is anticipated to reach USD 7.8 Billion by 2030. This is owing to rising number of ambulatory surgical centers and growing preference for outpatient soft tissue surgical procedures. Ambulatory surgical centers offer same-day surgical procedures along with cost-effective, high-quality services and can reduce the medical expenses by 45-60%. Clinical studies have indicated that surgery center performance usually exceeds that of hospital-based facilities, in terms of quality of soft tissue repair surgery and post-operative care.
 

Increasing prevalence of sports injuries in Germany will propel the soft tissue repair market progression

Germany market is likely to surpass USD 1.1 billion by 2030. This is due to the increasing incidence of sports injuries, significant product launches by key market players, rising number of tendon & wrist injuries, etc. Moreover, some of the prime variables propelling the market in Germany are growing accessibility to innovative technologies and effective surgical safety standards that promote the quality of soft tissue repair procedures.
 

Players are emphasizing on strategic initiatives and innovative product launch to expand business operations

Some of the major market players operating in the soft tissue repair industry are Smith & Nephew Plc., Medtronic Plc., Arthrex, Inc, Medprin Biotech, Zimmer Biomet, Stryker Corporation, and Baxter International, Inc. These players are engaged in strategic collaborations, partnerships, and agreements to gain competitive advantage over their competitors.
 

For instance, in March 2022, Zimmer Biomet signs an agreement with Biocomposites, a medical devices company that manufactures and markets products for regenerating bone and managing infection in the bone and soft tissue. This partnership is aimed to distribute the new Genex Bone Graft Substitute with its new mixing system and delivery options in the U.S. market.  This collaboration will offer a competitive advantage to the company.